These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 38105674)
21. Molecular diagnosis of maturity-onset diabetes of the young in a cohort of Chinese children. Xu A; Lin Y; Sheng H; Cheng J; Mei H; Ting TH; Zeng C; Liang C; Zhang W; Li C; Li X; Liu L Pediatr Diabetes; 2020 May; 21(3):431-440. PubMed ID: 31957151 [TBL] [Abstract][Full Text] [Related]
22. An extremely high blood glucose level in a child with hyperglycemic hyperosmolar state and type 1 diabetes. Butorac Ahel I; Severinski S; Lah Tomulic K; Milardovic A; Baraba Dekanic K; Palcevski D J Pediatr Endocrinol Metab; 2021 Aug; 34(8):1045-1048. PubMed ID: 33939902 [TBL] [Abstract][Full Text] [Related]
23. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age. Hokken-Koelega AC; van Pareren Y; Sas T; Arends N Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407 [TBL] [Abstract][Full Text] [Related]
24. Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues. Carroll MF; Izard A; Riboni K; Burge MR; Schade DS Diabetes Care; 2002 Dec; 25(12):2147-52. PubMed ID: 12453952 [TBL] [Abstract][Full Text] [Related]
25. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study. Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500 [TBL] [Abstract][Full Text] [Related]
26. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus]. Guo M; Xi G; Yang N; Yao H Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967 [TBL] [Abstract][Full Text] [Related]
27. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Turner R; Cull C; Holman R Ann Intern Med; 1996 Jan; 124(1 Pt 2):136-45. PubMed ID: 8554206 [TBL] [Abstract][Full Text] [Related]
28. Prediabetic markers in children with stress hyperglycemia. Bhisitkul DM; Vinik AI; Morrow AL; She JX; Shults J; Powers AC; Maclaren NK Arch Pediatr Adolesc Med; 1996 Sep; 150(9):936-41. PubMed ID: 8790124 [TBL] [Abstract][Full Text] [Related]
29. Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life span. RISE Consortium Diabetes Care; 2014; 37(3):780-8. PubMed ID: 24194506 [TBL] [Abstract][Full Text] [Related]
30. A novel mutation in GATA6 causes pancreatic agenesis. Stanescu DE; Hughes N; Patel P; De León DD Pediatr Diabetes; 2015 Feb; 16(1):67-70. PubMed ID: 24433315 [TBL] [Abstract][Full Text] [Related]
31. [The features of postprandial glucose state in type 2 diabetes mellitus]. Zhou J; Jia WP; Yu M; Ma XJ; Bao YQ; Lu W Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):970-5. PubMed ID: 16759538 [TBL] [Abstract][Full Text] [Related]
32. [Characteristics of newly diagnosed diabetes patients with young onset in the West China Hospital of Sichuan University]. Gong Y; Che TT; Liu SF; Ren Y Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):524-8. PubMed ID: 24941832 [TBL] [Abstract][Full Text] [Related]
33. Carbohydrate metabolism during long-term growth hormone treatment in children with short stature born small for gestational age. Sas T; Mulder P; Aanstoot HJ; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A Clin Endocrinol (Oxf); 2001 Feb; 54(2):243-51. PubMed ID: 11207640 [TBL] [Abstract][Full Text] [Related]
34. GCK gene mutations are a common cause of childhood-onset MODY (maturity-onset diabetes of the young) in Turkey. Haliloglu B; Hysenaj G; Atay Z; Guran T; Abalı S; Turan S; Bereket A; Ellard S Clin Endocrinol (Oxf); 2016 Sep; 85(3):393-9. PubMed ID: 27256595 [TBL] [Abstract][Full Text] [Related]
35. Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation. Falko JM; Osei K Am J Med; 1985 Sep; 79(3B):92-101. PubMed ID: 3931467 [TBL] [Abstract][Full Text] [Related]
36. A novel GATA6 mutation in patients with tetralogy of Fallot or atrial septal defect. Lin X; Huo Z; Liu X; Zhang Y; Li L; Zhao H; Yan B; Liu Y; Yang Y; Chen YH J Hum Genet; 2010 Oct; 55(10):662-7. PubMed ID: 20631719 [TBL] [Abstract][Full Text] [Related]
37. [Changes in carbohydrate metabolism and insulin resistance in patients with Prader-Willi Syndrome (PWS) under growth hormone therapy]. Lämmer C; Weimann E Wien Med Wochenschr; 2007 Feb; 157(3-4):82-8. PubMed ID: 17340066 [TBL] [Abstract][Full Text] [Related]
38. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison. Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076 [TBL] [Abstract][Full Text] [Related]
39. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Freemark M; Bursey D Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776 [TBL] [Abstract][Full Text] [Related]